Sebastian STARK

Person

Heidelberg, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Hydrogel cross-linked hyaluronic acid prodrug compositions and methods
- Patent number 11,642,415
- Issue date May 9, 2023
- Ascendis Pharma A/S
- Sebastian Stark
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
VEGF neutralizing prodrugs for the treatment of ocular conditions
- Patent number 10,519,226
- Issue date Dec 31, 2019
- Ascendis Pharma Opthalmology Division A/S
- Harald Rau
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Protecting group comprising a purification tag
- Patent number 10,040,850
- Issue date Aug 7, 2018
- Ascendis Pharma A/S
- Harald Rau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
HYDROGEL CROSS-LINKED HYALURONIC ACID PRODRUG COMPOSITIONS AND METHODS
- Publication number 20230414770
- Publication date Dec 28, 2023
- Ascendis Pharma A/S
- Sebastian STARK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HYDROGEL IRRADIATION
- Publication number 20230241217
- Publication date Aug 3, 2023
- Ascendis Pharma A/S
- Oliver Boris STAUCH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CTLA4 CONJUGATES
- Publication number 20220305136
- Publication date Sep 29, 2022
- Ascendis Pharma Oncology Division A/S
- Thomas KNAPPE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CONJUGATES OF PATTERN RECOGNITION RECEPTOR AGONISTS
- Publication number 20220062273
- Publication date Mar 3, 2022
- Ascendis Pharma Oncology Division A/S
- Kennett SPROGØE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MINIMIZATION OF SYSTEMIC INFLAMMATION
- Publication number 20220054478
- Publication date Feb 24, 2022
- Ascendis Pharma Oncology Division A/S
- David B. ROSEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUSTAINED LOCAL DRUG LEVELS FOR INNATE IMMUNE AGONISTS
- Publication number 20220054476
- Publication date Feb 24, 2022
- Ascendis Pharma Oncology Division A/S
- David B. ROSEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INDUCTION OF SUSTAINED LOCAL INFLAMMATION
- Publication number 20220054477
- Publication date Feb 24, 2022
- Ascendis Pharma Oncology Division A/S
- David B. ROSEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DEGRADABLE HYALURONIC ACID HYDROGELS
- Publication number 20210338834
- Publication date Nov 4, 2021
- Ascendis Pharma A/S
- Sebastian STARK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL HYDROGEL CONJUGATES
- Publication number 20210330807
- Publication date Oct 28, 2021
- Ascendis Pharma A/S
- Sebastian STARK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF INFECTIONS
- Publication number 20210330798
- Publication date Oct 28, 2021
- Ascendis Pharma A/S
- Kennett SPROGØE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HYDROGEL CROSS-LINKED HYALURONIC ACID PRODRUG COMPOSITIONS AND METHODS
- Publication number 20200222547
- Publication date Jul 16, 2020
- Genentech, Inc.
- Sebastian STARK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Protecting Group Comprising a Purification Tag
- Publication number 20180312582
- Publication date Nov 1, 2018
- Ascendis Pharma A/S
- Harald Rau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTECTING GROUP COMPRISING A PURIFICATION TAG
- Publication number 20160257739
- Publication date Sep 8, 2016
- Ascendis Pharma A/S
- Harald Rau
- C07 - ORGANIC CHEMISTRY
Information Patent Application
VEGF Neutralizing Prodrugs for the Treatment of Ocular Conditions
- Publication number 20150297740
- Publication date Oct 22, 2015
- Ascendis Pharma Ophthalmology Division A/S
- Harald RAU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Sebastian STARK

Person

Patents Grantslast 30 patents

Hydrogel cross-linked hyaluronic acid prodrug compositions and methods

VEGF neutralizing prodrugs for the treatment of ocular conditions

Protecting group comprising a purification tag

Patents Applicationslast 30 patents

HYDROGEL CROSS-LINKED HYALURONIC ACID PRODRUG COMPOSITIONS AND METHODS

HYDROGEL IRRADIATION

ANTI-CTLA4 CONJUGATES

CONJUGATES OF PATTERN RECOGNITION RECEPTOR AGONISTS

MINIMIZATION OF SYSTEMIC INFLAMMATION

SUSTAINED LOCAL DRUG LEVELS FOR INNATE IMMUNE AGONISTS

INDUCTION OF SUSTAINED LOCAL INFLAMMATION

DEGRADABLE HYALURONIC ACID HYDROGELS

NOVEL HYDROGEL CONJUGATES

TREATMENT OF INFECTIONS

HYDROGEL CROSS-LINKED HYALURONIC ACID PRODRUG COMPOSITIONS AND METHODS

Protecting Group Comprising a Purification Tag

PROTECTING GROUP COMPRISING A PURIFICATION TAG

VEGF Neutralizing Prodrugs for the Treatment of Ocular Conditions